Get the Stockscreener App
223.07
0.29%
-0.66
After Hours:
222.71
-0.36
-0.16%
Overview
News
Price History
Option Chain
Financials
Why DHR Down?
Discussions
Forecast
Stock Split
Dividend History
Danaher Corp stock is traded at $223.07, with a volume of 6.09M.
It is down -0.29% in the last 24 hours and down -2.87% over the past month.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
See More
Previous Close:
$223.73
Open:
$225
24h Volume:
6.09M
Relative Volume:
1.99
Market Cap:
$159.92B
Revenue:
$23.74B
Net Income/Loss:
$3.89B
P/E Ratio:
42.57
EPS:
5.24
Net Cash Flow:
$4.98B
1W Performance:
-9.20%
1M Performance:
-2.87%
6M Performance:
-18.94%
1Y Performance:
-8.93%
1-Day Range:
$221.34
$228.99
1-Week Range:
$221.34
$258.23
52-Week Range:
$221.34
$281.70
Danaher Corp Stock (DHR) Company Profile
Name
Danaher Corp
Sector
Industry
Phone
(202) 828-0850
Address
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
223.07 | 159.92B | 23.74B | 3.89B | 4.98B | 5.24 |
|
TMO
Thermo Fisher Scientific Inc
|
606.46 | 231.78B | 42.37B | 6.14B | 7.78B | 15.95 |
|
A
Agilent Technologies Inc
|
151.36 | 43.41B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
201.74 | 36.50B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
423.99 | 34.79B | 3.84B | 866.24M | 792.60M | 10.37 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-31-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-23 | Initiated | HSBC Securities | Hold |
| Dec-13-23 | Resumed | Wolfe Research | Peer Perform |
| Dec-07-23 | Downgrade | Goldman | Buy → Neutral |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-01-23 | Initiated | SVB Securities | Outperform |
| Apr-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-18-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Oct-24-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-17-22 | Resumed | Bernstein | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jun-01-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-11-22 | Initiated | Bernstein | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-10-21 | Reiterated | BofA Securities | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Reiterated | Goldman | Buy |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Apr-07-21 | Resumed | Robert W. Baird | Outperform |
| Mar-03-21 | Resumed | Barclays | Overweight |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-02-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-26-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-03-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Resumed | Stifel | Hold |
| Oct-28-19 | Reiterated | Needham | Buy |
| Oct-14-19 | Resumed | Credit Suisse | Outperform |
| Jul-19-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Feb-25-19 | Upgrade | Janney | Neutral → Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Apr-20-18 | Reiterated | Stifel | Buy |
View All
Danaher Corp Stock (DHR) Latest News
Investors Purchase Large Volume of Call Options on Danaher (NYSE:DHR) - MarketBeat
Ibex Wealth Advisors Invests $2.72 Million in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher (NYSE:DHR) Shares Gap Down Following Analyst Downgrade - MarketBeat
Danaher stock price target cut to $260 by TD Cowen - Investing.com India
Stifel cuts Danaher stock price target to $260 - Investing.com India
Danaher Fourth-Quarter Earnings Miss Estimates; Expects Decline in Core Revenue - MSN
RBC Capital cuts Danaher stock price target to $277 from $299 - Investing.com
Danaher Analysts Cut Their Forecasts After Downbeat Earnings - Benzinga
Why Danaher Corp. (DHR) Crashed on Wednesday? - MSN
Cortland Associates Inc. MO Trims Stock Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Zacks Earnings Trends Highlights: Royal Caribbean and Danaher - Yahoo Finance
Defender Capital LLC. Has $31.67 Million Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher revenues flat at USD 23.9 billion in 2024 - Medical Buyer
Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y - MSN
Danaher Corp. stock falls Wednesday, underperforms market - MSN
Danaher Corporation Reports Steady 2024 Financial Performance - TipRanks
Danaher misses quarterly profit estimates on weak biotech demand - MSN
Danaher Stock Tanks 8.6% After Rare Earnings Miss--Is the Growth Story Cracking? - GuruFocus.com
Beyond The Numbers: 5 Analysts Discuss Danaher Stock - Benzinga
BofA Cuts Danaher Stock Price Target to $265, Maintains Buy Rating - Investing.com Australia
Danaher stock touches 52-week low at $225.36 amid market shifts - MSN
We're cutting our price target on Danaher as frustration mounts after a messy quarter - CNBC
Danaher Dives: What This 8.6% Plunge Means for Investors - Jomfruland.net
Danaher Shares Tumble on Disappointing Forecast - TipRanks
DHR Earnings: Danaher Stock Falls 10% on Mixed Financial Results and Weak Guidance - TipRanks
Danaher (DHR) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Single Use Assemblies Market Global Forecasts to 2029: Rapid Growth in Single-Use Assemblies Market Driven by Biologics and Biosimilars Demand - GlobeNewswire Inc.
Danaher: Q4 Earnings Snapshot - Barchart
Danaher Had an Unusual Quarter. The Stock Is Down. - MSN
Danaher Stock Falls the Most Since 2023. Why Earnings Were Such a Disappointment. - Yahoo! Voices
Danaher Co. (NYSE:DHR) Shares Sold by Swedbank AB - MarketBeat
Danaher (NYSE:DHR) Posts Earnings Results, Meets Estimates - MarketBeat
Forsta AP Fonden Has $35.24 Million Stake in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) Stock Holdings Boosted by Montrusco Bolton Investments Inc. - MarketBeat
Stocks to Watch Wednesday: ASML, Danaher, Tesla, Trump Media - The Wall Street Journal
Danaher Co. (NYSE:DHR) Shares Purchased by Foster Victor Wealth Advisors LLC - MarketBeat
T-Mobile US, Starbucks, ASML rise premarket; Nvidia, Danaher fall - News.Az
Danaher Faces Challenges As Biotech Demand Dips - Finimize
Danaher dips after forecasting Q1 sales drop - MSN
Danaher (DHR) Lags Q4 Earnings Estimates - Yahoo Finance
Danaher Corp Exceeds Revenue and Adjusted EPS Estimates with $6. - GuruFocus.com
Danaher stock dips after seeing Q1 sales drop (DHR:NYSE) - Seeking Alpha
Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag - Yahoo Finance
Danaher 4Q Revenue Rises on Gains in Life Sciences, Biotech -January 29, 2025 at 06:45 am EST - Marketscreener.com
Danaher's Q4 Adjusted Earnings, Revenue Rise; Provides 2025 Revenue Guidance - Marketscreener.com
Danaher shares fall as Q4 earnings miss estimates, revenue beats By Investing.com - Investing.com Canada
Danaher shares fall as Q4 earnings miss estimates, revenue beats - Investing.com
Danaher: Q4 Earnings Snapshot -January 29, 2025 at 06:16 am EST - Marketscreener.com
Danaher earnings missed, revenue topped estimates By Investing.com - Investing.com Canada
Danaher earnings missed, revenue topped estimates - Investing.com
Earnings Flash (DHR) DANAHER CORPORATION Reports Q4 Adjusted EPS $2.14 -January 29, 2025 at 06:04 am EST - Marketscreener.com
Danaher Corp Stock (DHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):